Global Allergy Diagnostics and Treatments Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
The global allergy diagnostics and treatment market is expected to grow with CAGR of 12.67% in the forecasted period of 2016-2022. The key factors driving the global allergy diagnostics and treatments market are increasing allergies diseases, increasing IVD markets, increasing healthcare expenditure and increasing laboratory automation. Increasing respiratory allergies cases day by day is ultimately increasing the market of allergy diagnostics and treatments. According to American Academy of Allergy Asthma and Immunology (AAAAI), around 7.8 million children suffered from respiratory allergies worldwide. The increasing allergy cases in developing region is the key opportunity to drive the market of allergy diagnostics and treatments. The developing regions such as India, China has been on an uprising trend in terms of severity as well as prevalence. These allergic diseases contains asthma, rhinitis, anaphylaxis, drug, food and insect allergy and many more. Approx. 20% to 30 % of the total population suffers from at least one of these allergic diseases in India in which 20% to 30% of the population suffer from allergic rhinitis and that 15% develop asthma. Thus the increasing cases of allergy is driving the market of allergy diagnostic and treatment in India.
The market is majorly segmented on the basis of types, product and end users. On the basis of types, the market is further segmented as food, inhaled and others. On the product basis, the market is further segmented as assay kits, consumables and instruments. On the basis of end users the market is further segmented as academic research centers, diagnostic laboratories, hospitals and other users. Hospitals are the largest consumers of allergy diagnostic products. It is expected that this segment will accelerate with CAGR of over 11% in future years.
Based on types, product and end users the market is regionally segmented into North America, Europe, Asia Pacific and Rest of the world. North America holds the largest market share of allergy diagnostics and treatments and is followed by Europe. High technology and high investments in medical sector is promoting the growth of market. Moreover, every thirteen children having age of 18 years in U.S. is suffering from one or the other allergic problems. There are more than 17 million cases of food allergy in Europe and there have been seven times rise among children over the past decades.
Some of the major market players are Allercheck Laboratories, Inc., BioMerieux SA, Danaher Corporation, Hitachi Chemical Diagnostics, Inc., Omega Diagnostics Group plc. HOB Biotech Group Co., Ltd., HYCOR BioMedical, Lincoln Diagnostics, Inc., Siemens Healthcare, Stallergenes, and Thermo Fisher Scientific, Inc.. Acquisitions, merger and novel technology are the key strategies adopted by the market players to sustain in the market. As MeDALL allergen chip is used to determine allergies which helps to increase allergy diagnostics and treatments market globally. In Japan, in 2015 Stallergenes received approval for STG 320 which is the first tablet used in the treatment of house dust mite allergy.
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.
1. ALCON LABORATORIES 2. ALCON LABORATORIES, INC. 3. ALLERCHECK, INC. 4. BIOMERIEUX 5. DANAHER CORPORATION 6. HITACHI CHEMICAL DIAGNOSTICS 7. HOB BIOTECH GROUP 8. HYCOR BIOMEDICAL 9. LINCOLN DIAGNOSTICS 10. NIDEC CORP 11. OMEGA DIAGNOSTICS 12. SANOFI S.A 13. SIEMENS HEALTHCARE 14. STALLERGENES 15. THERMO FISHER SCIENTIFIC